Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
Clinical trial NCT02512042 · COMPLETED
Trial details
- NCT number
- NCT02512042
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-04-01
- Enrollment
- 973
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.